GNPX GENPREX INC Expansion Plans 8-K Filing 2024 - Research Collaboration Genprex, Inc. announced a Sponsored Research Agreement with the University of Michigan to study its drug candidate Reqorsa in combination with ALK-inhibitors for treating ALK-positive lung cancer, collaborating with ALK Positive to share costs.Get access to all SEC 8-K filings of the GENPREX INC